|
|
Volumn 118, Issue 1-2, 2008, Pages 36-41
|
|
Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with essential arterial hypertension
|
|
Author keywords
Coaguation; Endothelium; Essential hypertension; Fibrinolysis; TAFI
|
|
Indexed keywords
BETAXOLOL;
CREATININE;
D DIMER;
ENALAPRIL;
FIBRINOGEN;
FIBRINOLYTIC FACTOR;
PLASMIN;
PLASMIN ANTIPLASMIN COMPLEX;
PROTHROMBIN;
THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;
THROMBIN ANTITHROMBIN COMPLEX;
THROMBOMODULIN;
TRANSACTIVATOR PROTEIN;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
VON WILLEBRAND FACTOR;
ARTICLE;
ATHEROSCLEROSIS;
BLOOD PRESSURE;
BLOOD PRESSURE MONITORING;
CELL DAMAGE;
COMPARATIVE STUDY;
CONCENTRATION (PARAMETERS);
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DIASTOLIC BLOOD PRESSURE;
ECHOCARDIOGRAPHY;
ENDOTHELIUM CELL;
ESSENTIAL HYPERTENSION;
HEART EJECTION FRACTION;
HEART VENTRICLE SEPTUM;
HEMOSTASIS;
HUMAN;
MAJOR CLINICAL STUDY;
PROTEIN FUNCTION;
SYSTOLIC BLOOD PRESSURE;
THROMBIN TIME;
TRIACYLGLYCEROL BLOOD LEVEL;
|
|
EID: 39849095427
PISSN: 00323772
EISSN: None
Source Type: Journal
DOI: 10.20452/pamw.300 Document Type: Article |
|
Times cited : (17)
|
|
References (19)
|
